If diagnosed early, more than 90% of bowel cancer cases can be treated successfully and the five year survival rates for bowel cancer have doubled over the last 40 years. Screening tests healthy people to see if they show any early signs of cancer. By detecting bowel cancer at an early stage, treatment has the best chance of working.
The #1 Resource for Faecal Immunochemical Testing (FIT) in the UK and Eire
- [email protected]
- +44 (0) 23 8048 3000
Benefits of FIT
For Symptomatic Assessment
NICE DG30 recommends FIT for adoption in primary care to guide referral for suspected colorectal cancer in people without rectal bleeding who have unexplained symptoms but do not meet the criteria for a suspected cancer pathway referral outlined in NICE’s guideline on suspected cancer.
For Clinicians
Waiting times for endoscopy resources are increasing putting these departments under rising pressure. Performing an initial FIT test to categorise the patient could, with confidence, predict those for whom colonoscopy is not appropriate.
For Laboratories
The HM-JACKarc system is easy to set up and can be loaded with up to 80 samples at any one time. It can stand alone or be linked to the LIS, allowing flexible options for connectivity and full audit trail of results, QC and reagent lot numbers.
For Patients
Concerned about their condition, patients want quick answers, with minimal intervention. With FIT testing they can have access to more information about the symptoms they exhibit and the possible causes for them.
